← Leaderboards
Nicolas P Sluis-Cremer
University Of Pittsburgh At Pittsburgh
$13,171,852
Attributed
$15,210,062
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,210,062 · 10
By mechanism
R01$12,744,128 · 4
R21$1,675,955 · 4
R56$559,118 · 1
P50$230,861 · 1
Top collaborators
- Guillermo Alberto Calero4 shared
- Alexander Deiters4 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Peijun Zhang$11,080,362
- John W Mellors$70,850,753
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1InsightResistanceAntiretroviral TherapyRna-Directed Dna PolymeraseInfectionRibonuclease HPreventEnzymesNon-Nucleoside Reverse Transcriptase InhibitorsMolecularInhibitor/AntagonistDrug ResistanceDrug DevelopmentReverse Transcriptase InhibitorsPolymeraseReverse TranscriptionDna-Directed Dna PolymeraseMutationActive SitesPharmaceutical PreparationsBinding (Molecular Function)PhenotypePublic Health Relevance
Grant awards (42)
"On the Fly" Time Resolved Cryo-EM Studies of Intermediate HIV-1 RT Transition States$771,893
R01 · FY2025 · AI
Elucidating the role of B cell mediated trans infection in the establishment of the latent HIV-1 reservoir$728,506
R01 · FY2025 · AI · contact PI
"On the Fly" Time Resolved Cryo-EM Studies of Intermediate HIV-1 RT Transition States$771,893
R01 · FY2024 · AI
Elucidating the role of B cell mediated trans infection in the establishment of the latent HIV-1 reservoir$728,506
R01 · FY2024 · AI · contact PI
"On the Fly" Time Resolved Cryo-EM Studies of Intermediate HIV-1 RT Transition States$771,893
R01 · FY2023 · AI
Elucidating the role of B cell mediated trans infection in the establishment of the latent HIV-1 reservoir$728,506
R01 · FY2023 · AI · contact PI
Elucidating the role of B cell mediated trans infection in the establishment of the latent HIV-1 reservoir$778,686
R01 · FY2022 · AI · contact PI
"On the Fly" Time Resolved Cryo-EM Studies of Intermediate HIV-1 RT Transition States$741,636
R01 · FY2022 · AI
Potent inhibition of HIV-1 latency reversal by PF 03758309$188,921
R21 · FY2022 · AI · contact PI
Potent inhibition of HIV-1 latency reversal by PF 03758309$225,772
R21 · FY2021 · AI · contact PI
Mechanisms by which cyanotriazoles activate latent HIV$186,848
R21 · FY2019 · AI · contact PI
HIV-Reservoir in Naive CD+ T Cells$559,118
R56 · FY2018 · AI · contact PI
Novel mechanisms of HIV resistance to RTIs$385,000
R01 · FY2018 · AI · contact PI
Mechanisms by which cyanotriazoles activate latent HIV$225,892
R21 · FY2018 · AI · contact PI
Novel mechanisms of HIV resistance to RTIs$385,000
R01 · FY2017 · AI · contact PI
NNRTI induced conformational changes in HIV-1 RT$339,369
R01 · FY2017 · GM · contact PI
The "Kick" Revisited in the "Kick and Kill" Strategy$186,189
R21 · FY2017 · AI · contact PI
Novel mechanisms of HIV resistance to RTIs$385,000
R01 · FY2016 · AI · contact PI
NNRTI induced conformational changes in HIV-1 RT$339,577
R01 · FY2016 · GM · contact PI
The "Kick" Revisited in the "Kick and Kill" Strategy$223,397
R21 · FY2016 · AI · contact PI
Novel mechanisms of HIV resistance to RTIs$385,000
R01 · FY2015 · AI · contact PI
NNRTI induced conformational changes in HIV-1 RT$339,778
R01 · FY2015 · GM · contact PI
NNRTI induced conformational changes in HIV-1 RT - Equipment Supplement$55,000
R01 · FY2015 · GM · contact PI
NNRTI induced conformational changes in HIV-1 RT$339,974
R01 · FY2014 · GM · contact PI
Novel mechanisms of HIV resistance to RTIs$327,090
R01 · FY2012 · AI · contact PI
NNRTI induced conformational changes in HIV-1 RT$273,289
R01 · FY2012 · GM · contact PI
Novel mechanisms of HIV resistance to RTIs$327,090
R01 · FY2011 · AI · contact PI
NNRTI induced conformational changes in HIV-1 RT$273,456
R01 · FY2011 · GM · contact PI
Novel mechanisms of HIV resistance to RTIs$330,800
R01 · FY2010 · AI · contact PI
NNRTI induced conformational changes in HIV-1 RT$276,380
R01 · FY2010 · GM · contact PI
Novel mechanisms of HIV resistance to RTIs$168,154
R01 · FY2010 · AI · contact PI
Novel mechanisms of HIV resistance to RTIs$334,337
R01 · FY2009 · AI · contact PI
NNRTI induced conformational changes in HIV-1 RT$279,331
R01 · FY2009 · GM · contact PI
PROJECT 6$129,353
P50 · FY2008 · GM · contact PI
NNRTI induced conformational changes in HIV-1 Reverse Transcriptase$226,079
R01 · FY2007 · GM · contact PI
PROJECT 6$101,508
P50 · FY2007 · GM · contact PI
NNRTI induced conformational changes in HIV-1 RT$233,233
R01 · FY2006 · GM · contact PI
NNRTI induced conformational changes in HIV-1 RT$239,258
R01 · FY2005 · GM
HIV-1 RT dimerization as an antiviral target$222,750
R21 · FY2005 · AI
NNRTI induced conformational changes in HIV-1 RT$239,670
R01 · FY2004 · GM
HIV-1 RT dimerization as an antiviral target$216,186
R21 · FY2004 · AI
NNRTI induced conformational changes in HIV-1 RT$240,744
R01 · FY2003 · GM